Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
Treace Medical Concepts (NASDAQ:TMCI), a medical technology company focused on bunion and midfoot deformity treatments, will host an Investor Day on September 3, 2025, at 9:00 am ET in New York.
The event will feature presentations from management and experienced surgeons who will share their experiences with the company's expanded technology portfolio. Interested investors can register through investor relations by August 27, 2025. A live webcast and replay will be available on the company's investor relations website.
Treace Medical Concepts (NASDAQ:TMCI), un'azienda di tecnologia medica specializzata nel trattamento di alluci valghi e deformità del mesopiede, organizzerà un Investor Day il 3 settembre 2025 alle 9:00 ET a New York.
L'evento includerà presentazioni da parte del management e di chirurghi esperti che condivideranno le loro esperienze con il portafoglio tecnologico ampliato dell'azienda. Gli investitori interessati possono registrarsi tramite le relazioni con gli investitori entro il 27 agosto 2025. Saranno disponibili una diretta streaming e una registrazione sul sito delle relazioni con gli investitori dell'azienda.
Treace Medical Concepts (NASDAQ:TMCI), una empresa de tecnología médica centrada en tratamientos para juanetes y deformidades del mediopié, organizará un Día del Inversor el 3 de septiembre de 2025 a las 9:00 am ET en Nueva York.
El evento contará con presentaciones de la dirección y cirujanos experimentados que compartirán sus experiencias con la cartera tecnológica ampliada de la empresa. Los inversores interesados pueden registrarse a través de relaciones con inversores antes del 27 de agosto de 2025. Habrá una transmisión en vivo y una repetición disponibles en el sitio web de relaciones con inversores de la empresa.
Treace Medical Concepts (NASDAQ:TMCI)는 무지외반증 및 중족부 변형 치료에 중점을 둔 의료기술 회사로, 2025년 9월 3일 오전 9시(동부시간)에 뉴욕에서 투자자 설명회를 개최합니다.
이번 행사에서는 경영진과 경험 많은 외과의들이 회사의 확장된 기술 포트폴리오에 대한 경험을 공유하는 발표가 진행됩니다. 관심 있는 투자자는 2025년 8월 27일까지 투자자 관계 부서를 통해 등록할 수 있습니다. 회사 투자자 관계 웹사이트에서 생중계와 다시보기 서비스가 제공됩니다.
Treace Medical Concepts (NASDAQ:TMCI), une entreprise de technologie médicale spécialisée dans les traitements des oignons et des déformations du médio-pied, organisera une Journée Investisseurs le 3 septembre 2025 à 9h00 ET à New York.
L'événement comprendra des présentations de la direction et de chirurgiens expérimentés qui partageront leurs expériences avec le portefeuille technologique élargi de l'entreprise. Les investisseurs intéressés peuvent s'inscrire via les relations investisseurs avant le 27 août 2025. Une diffusion en direct et un replay seront disponibles sur le site des relations investisseurs de l'entreprise.
Treace Medical Concepts (NASDAQ:TMCI), ein Medizintechnikunternehmen, das sich auf Behandlungen von Hallux valgus und Mittelfußdeformitäten spezialisiert hat, veranstaltet am 3. September 2025 um 9:00 Uhr ET in New York einen Investorentag.
Die Veranstaltung umfasst Präsentationen des Managements und erfahrener Chirurgen, die ihre Erfahrungen mit dem erweiterten Technologieportfolio des Unternehmens teilen werden. Interessierte Investoren können sich bis zum 27. August 2025 über die Investor-Relations-Abteilung anmelden. Ein Live-Webcast und eine Aufzeichnung werden auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced plans to host an investor day at 9:00 am E.T. on September 3, 2025, in New York, New York. The event will include presentations by members of management and experienced surgeon users, highlighting their experiences with the expanded technology portfolio.
Investors interested in attending the event may request to register by contacting investor relations here, by August 27, 2025. A live webcast and replay of the Investor Day will be available on the Company’s investors relations website at https://investors.treace.com/.
Internet Posting of Information
Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.
About Treace Medical Concepts
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion surgeons and address the four classes of bunions, Treace introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP™ Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty™ 3D Minimally Invasive Bunion Correction System and the Percuplasty™ Percutaneous 3D Bunion Correction System. Treace continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate® Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty®, Adductoplasty® and SpeedMTP™ procedures, as well as other common bone fusion procedures of the foot. For more information, please visit www.treace.com.
To learn more about Treace, connect with us on LinkedIn, X, Facebook and Instagram.
Contacts:
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
mhair@treace.net
(904) 373-5940
Investors:
Gilmartin Group
Philip Trip Taylor
IR@treace.net
FAQ
When and where is Treace Medical (TMCI) hosting its 2025 Investor Day?
How can investors register for Treace Medical's 2025 Investor Day?
What will be presented at Treace Medical's 2025 Investor Day?
Where can investors access the webcast of TMCI's Investor Day?
